GlaxoSmithKline Consumer Nigeria PLC 1 Industrial Avenue, Ilupeju
RC 8726 PMB 21218 Ikeja, Lagos
Tel: +234 (01) 2711000, (01) 3242900 www.gsk.com/ng
Lagos, 31st March 2023
NOTICE OF SCHEDULED BOARD MEETING
This is to notify the General Public and the Exchange, that the Board of Directors' meeting of GlaxoSmithKline Consumer Nigeria Plc (the Company) scheduled to hold on Thursday, 30th March 2023 held as scheduled and the Board of directors approved:
1. The Audited Financial Statements of GlaxoSmithKline Consumer Nigeria Plc for the Year Ended 31st December 2022
The General Public should take note that the closed period for dealing in the Company's securities by the Directors, Managers or connected persons earlier announced will terminate 24 hours after the release of the approved Audited Financial Statements to the Market.
For: GlaxoSmithKline Consumer Nigeria PLC
Frederick Ichekwai
Company Secretary
Agbara Factory: Km 32, Igbesa Road, Agbara, Ogun State. Tel: +234 (01) 2918000.Email: Customer_ch_nigeria@gsk.com
Directors: Mr. Edmund Onuzo, Chairman; Mr. Kunle Oyelana, Managing Director; Mr. Samuel Kuye; Mr. Bosco Kirugi (Kenyan) Finance Director,
Mrs. Oludewa Edodo-Thorpe; D. Ms. Amina Salihu
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Glaxo Smithkline Consumer Nigeria plc published this content on 31 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 March 2023 12:04:05 UTC.